This pattern was consistent with the previously published analyses that uncovered cross-disorder opposite effects at lead SNPs near CD200, CD200R1 and DOK2 where the germline genetic associations were confined to basal cell carcinoma but the tumor immune gene expression correlations encompassed several additional cancer types [6]. The gene discussed is CD200; the disease is basal cell carcinoma.